Skip to main content
logo
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
92.08
+3.69 (4.17%)
At close: Feb 27, 2026, 4:00 PM EST
92.09
+0.01 (0.01%)
After-hours: Feb 27, 2026, 5:48 PM EST

Protagonist Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5,8765,4602,3001,3235371,632
Market Cap Growth
166.52%137.35%73.94%146.40%-67.12%88.22%
Enterprise Value
5,2404,7921,7281,0022741,286
Last Close Price
92.0887.3438.6022.9310.9134.20
PE Ratio
--8.36---
Forward PE
26.8059.76----
PS Ratio
127.68118.665.3022.0420.1959.67
PB Ratio
9.378.883.413.932.495.44
P/TBV Ratio
9.568.883.413.932.495.44
P/FCF Ratio
104.7797.3612.59---
P/OCF Ratio
101.8894.6812.49---
EV/Sales Ratio
113.87104.143.9816.6910.2947.01
EV/EBITDA Ratio
--6.81---
EV/EBIT Ratio
--6.84---
EV/FCF Ratio
93.4385.459.45---
Debt / Equity Ratio
0.020.020.020.000.020.02
Debt / EBITDA Ratio
--0.04---
Debt / FCF Ratio
0.180.180.06---
Net Debt / Equity Ratio
-1.03-1.03-0.81-1.01-1.08-1.07
Net Debt / EBITDA Ratio
4.054.05-2.163.671.792.57
Net Debt / FCF Ratio
-11.33-11.33-3.004.812.152.95
Asset Turnover
0.070.070.790.200.090.08
Quick Ratio
12.5912.5912.3916.547.617.55
Current Ratio
12.7112.7112.4816.717.807.74
Return on Equity (ROE)
-20.18%-20.18%54.39%-28.59%-49.41%-43.32%
Return on Assets (ROA)
-13.99%-13.99%28.66%-19.32%-27.57%-23.40%
Return on Invested Capital (ROIC)
-229.61%-97.34%189.05%---
Return on Capital Employed (ROCE)
-25.40%-25.40%36.30%-27.80%-60.60%-41.40%
Earnings Yield
-2.22%-2.38%11.96%-5.97%-23.73%-7.69%
FCF Yield
0.95%1.03%7.95%-5.36%-20.29%-6.68%
Buyback Yield / Dilution
2.31%2.31%-14.65%-15.74%-5.87%-34.67%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q